HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

1326studies shown
Showing 673-684 of 1,326
Other study type icon
CompletedNCT03655730

Efficacity of Psychological Intervention on Reducing the Suicidal Ideations, Depression Level and Improving Reinsertion

Official study title

Efficacity of a Sustained Weekly Psychological Intervention for Adolescents and Young Adults Attending to Local Missions for Reinsertion, on Reducing the Suicidal Ideations, Depression Level and Improving Reinsertion Compared to Usual Care

This study has finished and is no longer accepting participants.

In France
DepressionInterventional studyAges 16–25
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
View study
Drug study icon
CompletedEUCTR 2007-003312-65

Efficacy and safety of 2 doses of S 90098 (1 and 2mg/day), sublingual formulation for 8 weeks in out-patients with Major Depressive Disorder. An 8-week randomised, double-blind, fixed dose, interna...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
DepressionHistorical research record
Countries
France, Czechia, Estonia, + 2 others
Sponsor
Institut de Recherches Internationales Servier
View study
Drug study icon
CompletedEUCTR 2009-014045-92

Efficacy and safety of 3 doses (0.25, 0.5 and 1mg/day) of agomelatine sublingual administration over an 8-week treatment period, in out-patients with Major Depressive Disorder. An 8-week randomis...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
DepressionHistorical research record
Countries
France, Czechia, Estonia, + 2 others
Sponsor
Institut de Recherches Internationales Servier
View study
Drug study icon
CompletedNCT01785147

BP1.4979 for Addiction

Official study title

Randomized Placebo Controlled Trial Assessing the Efficacy and Safety of BP1.4979 in Smoking Cessation

This study has finished and is no longer accepting participants.

In France
AddictionMedication studyAges 18–65
Countries
France
Sponsor
Bioprojet
View study
Drug study icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

What is this study about?

This study evaluated the safety and effectiveness of Extended-release Guanfacine Hydrochloride for people with ADHD.

This study has finished and is no longer accepting participants.

In France
ADHDMedication studyAges 6–17
Countries
France, United States, Canada, + 10 others
Sponsor
Shire
View study
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

What is this study about?

Researchers are comparing Lu AA34893 and placebo to find out how the approaches affect depression symptoms in people with bipolarity type I or II.

This study ended early.

In France
Bipolarity, DepressionMedication studyAges 18–65
Countries
France, Australia, Canada, + 15 others
Sponsor
H. Lundbeck A/S
View study
Drug study icon
CompletedNCT00481975

Rimonabant on Weight Loss and Frequency of Binge Episodes for Eating disorders

Official study title

A Randomized, Double-Bind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study to Assess Efficacy and Safety of Rimonabant 20 mg Versus Placebo on Weight Loss and Frequency of Binge Episodes in Obese Patients With Food Craving

This study has finished and is no longer accepting participants.

In France
Eating disordersMedication studyAges 18–70
Countries
France, United States, Switzerland, + 4 others
Sponsor
Sanofi
View study
Drug study icon
CompletedEUCTR 2006-006540-54

Efficacy of agomelatine (25 to 50 mg/day) given orally on improvement of subjective sleep in patients with Major Depressive Disorder. A randomised, double-blind, flexible-dose international multice...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
DepressionHistorical research record
Countries
France, United Kingdom
Sponsor
Institut de Recherches Internationales Servier
View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.